Table 1. Clinical profile and metabolic and hormonal variables of the PCOS and control groups.
Variable | Phenotypes A and B (n = 59) | Phenotype C (n = 23) | Controls (n = 51) | p |
---|---|---|---|---|
Age, years | 26 (20–30) a | 29 (22–32) ab | 28 (24–32) b | 0.015 |
BMI, kg/m2 | 32.3 (25.9–36.4) a | 27.2 (23.9–29.6) b | 26.7 (23.0–31.1) b | 0.002 |
BMI ≥ 25 kg/m2 | 45 (77.6%) | 15 (71.4%) | 28 (59.6%) | 0.133 |
DBP, mm Hg | 80 (72–81) a | 77 (70–80) ab | 70 (67–80) b | 0.002 |
SBP, mm Hg | 120 (110–130) a | 120 (115–125) ab | 110 (105–120) b | 0.001 |
Ferriman-Gallwey score | 15.0 (9.5–19.5) a | 12.0 (9.0–19.2) a | 03 (1.7–5.0) b | <0.001 |
TT, ng/mL | 0.65 (0.48–0.82) a | 0.60 (0.44–0.70) ab | 0.50 (0.41–0.63) b | 0.008 |
SHBG, nmol/L | 28.2 (18.9–42.0) a | 29.7 (16.6–44.4) a | 35.7 (29.7–53.6) b | <0.001 |
FAI | 2.28 (1.42–4.38) a | 1.95 (1.36–2.89) a | 1.28 (0.81–2.10) b | <0.001 |
Progesterone, ng/mL | 0.80 (0.59–1.41) a | 7.39 (5.77–11.53) b | 6.44 (0.80–8.56) b | <0.001 |
Glucose, mg/dL | 87 (82–92) | 86 (82–90) | 86 (81–92) | 0.639 |
Insulin, μU/mL | 16.49 (7.81–22.34) a | 15.00 (7.02–20.61) ab | 9.05 (6.14–12.36) b | 0.006 |
HOMA-IR | 3.52 (1.53–5.22) a | 3.40 (1.50–4.33) ab | 1.93 (1.34–2.53) b | 0.008 |
Triglycerides, mg/dL | 103 (59–155) a | 87 (66–133) ab | 75 (55–105) b | 0.011 |
Total cholesterol, mg/dL | 180 ± 35 | 177 ± 34 | 177 ± 27 | 0.873 |
HDL, mg/dL | 43 (37–52) a | 47 (39–55) ab | 50 (43–60) b | 0.010 |
LDL, mg/dL | 107 (87–136) | 98 (88–134) | 107 (91–122) | 0.583 |
Metabolic syndrome | 21 (35.6%) a | 3 (13.0%) b | 3 (5.9%) b | <0.001 |
Creatinine, mg/dL | 0.69 ± 0.08 | 0.68 ± 0.12 | 0.66 ± 0.08 | 0.403 |
Total fat mass, kg | 36.05 ± 12.42 a | 29.81 ± 7.83 ab | 29.06 ± 10.86 b | 0.005 |
FMI, kg/m2 | 14.08 (10.18–17.46) a | 11.14 (8.80–12.71) ab | 10.54 (7.99–15.20) b | 0.015 |
Total lean mass, kg | 40.92 (36.19–47.23) a | 39.78 (36.08–42.71) ab | 38.07 (35.21–40.82) b | 0.010 |
ALMI, kg/m2 | 7.01 (6.33–8.02) a | 6.60 (6.16–7.22) ab | 6.69 (5.94–7.09) b | 0.020 |
Lumbar spine BMD, g/cm2 | 1.258 ± 0.120 a | 1.249 ± 0.101 ab | 1.194 ± 0.136 b | 0.027 |
Z-score | 0.7 ± 0.9 a | 0.5 ± 0.8 ab | 0.1 ± 1.1 b | 0.014 |
Total femur BMD, g/cm2 | 1.109 ± 0.143 a | 1.064 ± 0.112 ab | 1.017 ± 0.163 b | 0.013 |
Z-score | 0.5 ± 1.1a | 0.0 ± 0.6 ab | −0.1 ± 1.0 b | 0.004 |
Data are expressed as mean ± SD, median (IQR), or percentage. P-value by one-way ANOVA or Pearson’s chi-square test. Different lowercase letters in the same row indicate statistically significant differences. PCOS: polycystic ovary syndrome; BMI: body mass index; DBP: diastolic blood pressure; SBP: systolic blood pressure; TT: total testosterone; SHBG: sex hormone–binding globulin; FAI: free androgen index; HOMA-IR: homeostasis model assessment of insulin resistance index; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; FMI: fat mass index; ALMI: appendicular lean mass index; BMD: bone mineral density.